Expanding Access to the Self-Administered Contraceptive Injection

Depot medroxyprogesterone acetate (DMPA), often referred to by the brand name, Depo Provera, or “the depo shot,” is birth control that is administered as an injection every three months to prevent pregnancy. The most common form is an intramuscular injection, which usually involves going to a health care provider — like a doctor, nurse, or…

Hormonal Contraception, Breast Cancer, and Communicating Risk to Patients

This Contraceptive Pearl clarifies how to communicate risk to address questions regarding cancer risk for users of hormonal contraception.

Insights: Reasonable Accommodations For Patients with Disabilities

Sign-up to Receive Insights Monthly! If you enjoyed this Insights, sign up to have them delivered to your inbox! Insights are released on the fourth Tuesday of every month! Written by Jillian MacLeod Patients with disabilities are much more likely than nondisabled patients to experience barriers to reproductive healthcare, including barriers in the clinic.1 Common…

Insights: Crisis Pregnancy Centers: Best Practices for Patient Guidance

Sign-up to Receive Insights Monthly! If you enjoyed this Insights, sign up to have them delivered to your inbox! Insights are released on the fourth Tuesday of every month! Written by Mackenzie Wills, DO and Maya Bass MD MA FAAFP Online searches for abortion or pregnancy services can lead patients to crisis pregnancy centers (CPCs).…

Insights: Shield Laws and Telemed Abortion

Sign-up to Receive Insights Monthly! If you enjoyed this Insights, sign up to have them delivered to your inbox! Insights are released on the fourth Tuesday of every month! Updated 08/25/2026 Written by Dineli Lewke, DO and Maya Bass, MD In June 2022, the U.S. Supreme Court decision in Dobbs v. Jackson Women’s Health Organization…

Insights: Updates in Recurrent Pregnancy Loss

Written by Tatiana Vazquez De Los Santos, MD, and C. Peony Khoo, MD Recurrent pregnancy loss (RPL) – defined as 2 or more spontaneous pregnancy losses – has a prevalence of at least 2%.1 Discrepancies exist between couples’ and medical professionals’ perceptions of pregnancy loss.2 For example, couples surveyed in one study out of Denmark…

Insights: Medication Abortion 14 to 20 Weeks

Written by Libby Wetterer, MD and Gabriele Ruzgas, MD Medication abortion accounts for approximately 65% of abortions in the United States.1 Most U.S. clinicians who provide medication abortion do so through 12 weeks gestation, though medication abortion can be used later in pregnancy. Data shows that up to 24 weeks fetal expulsion rates are 90%…

Insights: Keeping Pregnant Patients Safe Amid State-Sponsored Violence

Written by rachna vanjani, md As we witness the rise of authoritarianism and state-sponsored violence, it is important for reproductive health clinicians to recognize forms of systemic oppression and how they affect care for pregnant people in our communities. State-sponsored violence against pregnant people uses legal, police, and institutional systems to control, punish, or force…

Insights: Ensuring Effective Communication for Disabled Patients

Written by Jillian MacLeod Effective communication is essential for building trust with patients, supporting decision-making capacity, and providing quality medical care–including abortion care. For patients with disabilities that affect communication, it can be the difference between access to quality abortion care and complete denial of care. People with communication disabilities are much more likely to…

Reproductive Health Care and Advocacy Fellowship

The Reproductive Health Care and Advocacy Fellowship is a year-long intensive clinical training program that develops a diverse community of family medicine leaders to provide, teach, and advocate for access to equitable and person-centered reproductive health care, especially within primary care. We envision a vibrant and diverse community of clinical leaders and change-makers with the…